ClinicalTrials.govpublic full text
QL1706 Combined With Chemotherapy in the Treatment of Immune-mediated NSCLC
nsclc (advanced non-small cell lung cancer), nsclc, immune resistance, pd-1/ctla-4, egfr/alk mutation negative, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 865786
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.